Is an SDS the same as a COA?

No. An SDS communicates hazard and safety information for a material. A COA reports specified analytical results for a named sample or lot. They have different purposes and neither document replaces the other.

Does an SDS prove a peptide's purity or identity?

No. An SDS is not a lot-specific analytical certificate. Check a COA or laboratory report for the identity, method and batch-specific results that are actually shown.

Does an SDS establish that a material is safe for human use?

No. An SDS does not establish clinical safety, efficacy, regulatory status or suitability for human use.

How to Read a Peptide Safety Data Sheet (SDS)

A Safety Data Sheet, often shortened to SDS, is a structured document for communicating chemical hazard information. It can be useful alongside peptide documentation, but it has a different purpose from a certificate of analysis. This guide shows how to read it without asking it to prove more than it can.

Start with the document’s purpose

Under the widely used 16-section format, a Safety Data Sheet is designed to communicate information about a substance or mixture, including identified hazards, handling, transport and other safety-related information. The format makes it easier to find the same type of information across documents.

That purpose matters. An SDS is not an analytical report. It should be read as a safety-information record for the named material, not as a substitute for evidence about a particular batch.

The sections worth locating first

Section 1: Identification. Note the product identifier, supplier name and contact details. This helps establish what document you are looking at.
Section 2: Hazard identification. Check the classification, signal word, hazard statements and pictograms that are actually listed. Do not infer a missing classification from marketing language.
Section 3: Composition or information on ingredients. Read the identity information that is provided, while recognizing that an SDS may not provide a sequence, lot number or analytical method.
Sections 7–8: Handling, storage and exposure controls. These sections communicate workplace-style safety information. Their presence does not turn the page into use instructions or medical guidance.
Section 9: Physical and chemical properties. Record what is stated, and avoid filling gaps with assumptions from another product or form.
Section 11: Toxicological information. Read the wording and cited basis carefully. This section does not establish clinical safety or suitability for human use.
Section 16: Other information. Look for the preparation or revision date. It tells you about the document’s currency, not necessarily about a specific production lot.

SDS versus COA: two documents, two questions

Document	Useful question	What it does not establish by itself
Safety Data Sheet (SDS)	What hazard and safety information does this document communicate for the named material?	Lot-specific purity, lot-specific identity, clinical safety or suitability for human use.
Certificate of Analysis (COA)	What analytical results and specifications are reported for the named sample or lot?	Safety, efficacy, regulatory status, chain of custody after release or results for a different lot.

For the analytical side, use How to Read a Peptide COA: 7 Evidence Checks. To understand the value of lot matching, see Lot Traceability: Connect a Product, COA and Lab Record.

A careful reading checklist

Confirm that the document names a specific product or material rather than a broad, unrelated category.
Record the supplier or issuer, document revision date and any document identifier.
Check whether the product name on the SDS aligns with the product page and the COA — without assuming they refer to the same lot.
Keep hazard statements separate from claims about efficacy, quality or human use.
Where a field is missing, write “not stated” rather than drawing a conclusion from the absence.
Use a COA or laboratory report for batch-specific analytical questions, if one is available.

Signals to keep visible

An SDS can be professionally formatted and still be limited. A generic SDS that does not clearly identify the material, a document with no revision date, or an SDS that cannot be connected to a product page should be recorded as an unresolved documentation gap. That is not proof of a defect; it is a reason not to overstate what the document shows.

Similarly, an SDS is not a product endorsement. It does not establish that a material is safe, effective, legal or appropriate for any particular person or purpose.

Where the 16-section structure comes from

OSHA describes a standardized 16-section SDS format, including identification, hazards, composition, exposure controls, toxicological information and document revision details. The European Chemicals Agency also describes SDSs as records that provide information about the properties and hazards of a substance or mixture. These are useful frameworks for reading the document; local requirements can vary.

To compare a document against wider supplier information without turning it into a verdict, use How to Evaluate Peptide Supplier Information and the Supplier Evidence Checklist.